Page 54 - GALENIKA MEDICAL JOURNAL
P. 54

the type 1 interferon response in dengue virus infection. Sci Rep. 2017   56.  Zhang Q, Yang H, Wang J, Li A, Zhang W, Cui X, et al. Effect of green tea
             Feb 20;7:42998.                                    on reward learning in healthy individuals: a randomized, double-blind,
                                                                placebo-controlled pilot study. Nutr J. 2013 Jun 18;12:84.
          45.  Liu T, Zang N, Zhou N, Li W, Xie X, Deng Y, et al. Resveratrol inhibits
             the TRIF-dependent pathway by upregulating sterile alpha and   57.  Dong X, Yang C, Cao S, Gan Y, Sun H, Gong Y, et al. Tea consumption
             armadillo motif protein, contributing to anti-inflammatory effects after   and the risk of depression: a meta-analysis of observational studies.
             respiratory syncytial virus infection. J Virol. 2014 Apr;88(8):4229-36.  Aust N Z J Psychiatry. 2015 Apr;49(4):334-45.
          46.  Shepard CW, Finelli L, Alter MJ..Global epidemiology of hepatitis C virus   58.  Zhang WF, Tan YL, Zhang XY, Chan RC, Wu HR, Zhou DF. Extract of
             infection. Lancet Infect Dis 2005; 5:558-67.       Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a
                                                                randomized, double-blind, placebo-controlled trial. J Clin Psychiatry.
          47.  Chan CN, Trinité B, Levy DN. Potent Inhibition of HIV-1 Replication   2011 May;72(5):615-21.
             in Resting CD4 T Cells by Resveratrol and Pterostilbene. Antimicrob
             Agents Chemother. 2017 Aug 24;61(9):e00408-17.   59.  Uebel-von Sandersleben H, Rothenberger A, Albrecht B, Rothenberger
                                                                LG, Klement S, Bock N. Ginkgo biloba extract EGb 761® in children with
          48.  Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T. Resveratrol inhibition   ADHD. Z Kinder Jugendpsychiatr Psychother. 2014 Sep;42(5):337-47.
             of varicella-zoster virus replication in vitro. Antiviral Res. 2006
             Dec;72(3):171-7.                                60.  Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, et al.
                                                                Favorable effects of berry consumption on platelet function, blood
          49.  Zhu Y, He W, Gao X, Li B, Mei C, Xu R, et al. Resveratrol overcomes   pressure, and HDL cholesterol. Am J Clin Nutr. 2008 Feb;87(2):323-31.
             gefitinib resistance by increasing the intracellular gefitinib
             concentration and triggering apoptosis, autophagy and senescence in   61.  Momose Y, Maeda-Yamamoto M, Nabetani H. Systematic review of
             PC9/G NSCLC cells. Sci Rep. 2015 Dec 4;5:17730.    green tea epigallocatechin gallate in reducing low-density lipoprotein
                                                                cholesterol levels of humans. Int J Food Sci Nutr. 2016 Sep;67(6):606-13.
          50.  Christensen KY, Naidu A, Parent MÉ, Pintos J, Abrahamowicz M,
             Siemiatycki J, et al. The risk of lung cancer related to dietary intake of   62.  Xie L, Vance T, Kim B, Lee SG, Caceres C, Wang Y, et al. Aronia berry
             flavonoids. Nutr Cancer. 2012;64(7):964-74.        polyphenol consumption reduces plasma total and low-density
                                                                lipoprotein cholesterol in former smokers without lowering biomarkers
          51.  Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S,   of inflammation and oxidative stress: a randomized controlled trial.
             et al. Association between habitual dietary flavonoid and lignan intake   Nutr Res. 2017 Jan;37:67-77.
             and colorectal cancer in a Spanish case-control study (the Bellvitge
             Colorectal Cancer Study). Cancer Causes Control. 2013 Mar;24(3):549-  63.  Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol
             57.                                                supplementation on cardiovascular risk factors in patients with non-
                                                                alcoholic fatty liver disease: a randomised, double-blind, placebo-
          52.  Tse G, Eslick GD. Soy and isoflavone consumption and risk of   controlled study. Br J Nutr. 2015 Sep 14;114(5):796-803.
             gastrointestinal cancer: a systematic review and meta-analysis. Eur J
             Nutr. 2016 Feb;55(1):63-73.                     64.  Cao X, Liao W, Xia H, Wang S, Sun G. The Effect of Resveratrol on Blood
                                                                Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled
          53.  Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M. Flavonoids,   Trials. Nutrients. 2022 Sep 11;14(18):3755.
             flavonoid subclasses and breast cancer risk: a meta-analysis of
             epidemiologic studies. PLoS One. 2013;8(1):e54318.
          54.  Wang Y, Gapstur SM, Gaudet MM, Peterson JJ, Dwyer JT, McCullough   Konflikt interesa: Nema
             ML. Evidence for an association of dietary flavonoid intake with
             breast cancer risk by estrogen receptor status is limited. J Nutr. 2014   Primljeno: 22. 01. 2023.
             Oct;144(10):1603-11.
                                                                Prihvaćeno: 20. 03. 2023.
          55.   Fagundes MA, Silva ARC, Fernandes GA, Curado MP. Dietary Polyphenol   Onlajn: 01. 09. 2023.
             Intake and Gastric Cancer: A Systematic Review and Meta-Analysis.
             Cancers (Basel). 2022 Nov 29;14(23):5878.











































          52     DOI: 10.5937/Galmed2307046B
   49   50   51   52   53   54   55   56   57   58   59